SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001387131-21-004112
Filing Date
2021-04-01
Accepted
2021-04-01 17:03:55
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT tnxp-s3_040121.htm S-3 177008
2 ex5-01.htm EX-5.01 16553
3 OPINION OF LOWENSTEIN SANDLER, LLP ex5-02.htm EX-5.02 15674
4 CONSENT OF EISNERAMPER LLP ex23-01.htm EX-23.01 2889
5 GRAPHIC tnxp-001.jpg GRAPHIC 10457
6 GRAPHIC ex5-2_img001.jpg GRAPHIC 3957
7 GRAPHIC ex5-2_img002.jpg GRAPHIC 7506
  Complete submission text file 0001387131-21-004112.txt   243792
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254975 | Film No.: 21799034
SIC: 2834 Pharmaceutical Preparations